Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study

Table 3 MAP during anesthesia (n = 60 in each group)

MAP (mmHg)	T₀	T₁	T₂	T₃	T₄
Propofol group	98.7 ± 9.2	83.9 ± 14.4	83.9 ± 9.0	85.7 ± 9.8	80.5 ± 9.5
Remimazolam group	98.3 ± 8.4	85.6 ± 15.3	85.5 ± 13.0	89.6 ± 10.3	82.2 ± 9.6
F-value _{group/time/time × group}		1.986/52.52/0.678
P-value _{group/time/time × group}		0.161/<0.001/0.578

Notes: Data for MAP are presented as mean ± standard deviation. T₀: baseline; T₁: 10 min after induction; T₂: 10 min after beginning surgery; T₃: 30 min after beginning surgery; T₄: 60 min after beginning surgery
Abbreviations: MAP, mean arterial pressure

ISSN: 1471-2253